News
Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone
Friday, March 8 2024 | 08 h 52 min | News
Vivity is the most implanted extended depth of focus (EDOF) intraocular lens (IOL) globally
Read More
Ted Lasso Director Takes on New Specsavers ‘Should’ve Gone to Specsavers’ Campaign ‘Airport’
Thursday, March 7 2024 | 11 h 17 min | News
Specsavers Canada launched its new 'Should've Gone to Specsavers' campaign with a spot called 'Airport'.
Read More
Opto-Réseau Expands with ‘C’est la vue’ Clinic in Ahuntsic-Cartierville
Thursday, March 7 2024 | 10 h 59 min | News
Founded in 1989, 'C'est la vue' has built a strong reputation as a reference in optics in the Ahuntsic-Cartierville neighborhood.
Read More
SS24 VANGUARD Collection: The Epitome of Sophistication and Sustainability
Wednesday, March 6 2024 | 13 h 05 min | Frames Fashion
The new GIGI STUDIOS SS24 VANGUARD collection comprises lighter, hand-crafted models of reduced weight thanks to thinner acetates and carefully designed inner bezels.
Read More
Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters
Tuesday, March 5 2024 | 13 h 28 min | News
Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.
Read More
CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care
Tuesday, March 5 2024 | 10 h 46 min | News
MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights
Read More
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners
Tuesday, March 5 2024 | 10 h 17 min | News
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.
Read More
Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.
Read More
Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024
Monday, March 4 2024 | 15 h 54 min | News
The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.
Read More
Balancing Style and Functionality in Frame Selection
Monday, March 4 2024 | 09 h 54 min | Frames Fashion
From the moment a patient steps into the dispensary, they are met with a unique prescription and a set of preferences.
Read More
